New drug tested for hospitalized heart failure patients
NCT ID NCT06556810
Summary
This is a small, early-stage study to see if a new drug called atibuclimab (IC14) is safe and might help people who are hospitalized because their heart failure has suddenly gotten worse. The study will enroll 10 adults to receive a single IV infusion of the drug and then be closely monitored. Researchers will check for side effects and look for early signs that the drug reduces inflammation and improves heart failure symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE DECOMPENSATED HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Virginia
Charlottesville, Virginia, 22908, United States
-
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
Conditions
Explore the condition pages connected to this study.